Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Capizzi

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Cancer Treatment Reports|July 1, 1985
Phase I study of high-dose cytarabine and cisplatin in patients with advanced malignancyJ N Atkins, H B Muss, R L Capizzi, et al.
Seminars in Oncology|March 1, 1985
Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA)H B Muss, E H Paschold, W R Black, et al.
Blood|March 1, 1984
Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginaseR L Capizzi, M Poole, M R Cooper, et al.
Surgery, Gynecology & Obstetrics|April 1, 1989
Chemoinfusion of the hepatic artery for metastases to the liverJ M Sterchi, F Richards, D R White, et al.
Investigational New Drugs|January 1, 1986
Recombinant gamma interferon in advanced breast cancer: a phase II trialH B Muss, M Caponera, P J Zekan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancerR A Fleming, R L Capizzi, H B Muss, et al.
Seminars in Oncology|June 1, 1985
Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Leukemia|January 1, 1989
Low-dose ara-C therapy for acute myelogenous leukemia in elderly patientsB L Powell, R L Capizzi, H B Muss, et al.
Leukemia|March 1, 1988
Low dose Ara-C for patients with myelodysplastic syndromesB L Powell, R L Capizzi, D V Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancerJ C Marsh, J R Bertino, K H Katz, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Cancer Treatment Reports|July 1, 1985
Phase I study of high-dose cytarabine and cisplatin in patients with advanced malignancyJ N Atkins, H B Muss, R L Capizzi, et al.
Seminars in Oncology|March 1, 1985
Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA)H B Muss, E H Paschold, W R Black, et al.
Blood|March 1, 1984
Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginaseR L Capizzi, M Poole, M R Cooper, et al.
Surgery, Gynecology & Obstetrics|April 1, 1989
Chemoinfusion of the hepatic artery for metastases to the liverJ M Sterchi, F Richards, D R White, et al.
Investigational New Drugs|January 1, 1986
Recombinant gamma interferon in advanced breast cancer: a phase II trialH B Muss, M Caponera, P J Zekan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1996
Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancerR A Fleming, R L Capizzi, H B Muss, et al.
Seminars in Oncology|June 1, 1985
Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemiaR L Capizzi, B L Powell, M R Cooper, et al.
Leukemia|January 1, 1989
Low-dose ara-C therapy for acute myelogenous leukemia in elderly patientsB L Powell, R L Capizzi, H B Muss, et al.
Leukemia|March 1, 1988
Low dose Ara-C for patients with myelodysplastic syndromesB L Powell, R L Capizzi, D V Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancerJ C Marsh, J R Bertino, K H Katz, et al.
Pageof 13